{
    "nctId": "NCT02257580",
    "officialTitle": "The Effect of Intravenous E-Aminocaproic Acid (EACA) on Blood Loss and Transfusion Requirements After Bilateral Varus Rotational Osteotomy (VRO)",
    "inclusionCriteria": "* Scheduled for bilateral varus rotational osteotomy (VRO) with or without associated soft tissue and osseous procedures\n* Must have minimum age of 1 Year\n* Must have maximum age of 18 Years",
    "exclusionCriteria": "* Preoperative use of an anticoagulant (Plavix, warfarin, lovenox, etc.)\n* History of hypersensitivity to EACA\n* History of thromboembolic event (e.g., PE or DVT)\n* History of renal insufficiency or failure\n* Congenital or acquired coagulopathy as evidence by INR \\>1.4 or PTT \\> 1.4 times normal, or Platelets \\<150,000/mm3 on preoperative laboratory testing\n* Use of hormone replacement therapy or hormonal contraceptive agents within days prior to surgery\n* Use of acetylsalicylic acid (ASA), antiplatelet agents within 7 days prior to surgery\n* Pregnant\n* Breastfeeding\n* Not received neuraxial anesthesia"
}